Laaksonen, Niina https://orcid.org/0000-0001-6764-5397
Bengtström, Mia
Axelin, Anna
Blomster, Juuso
Scheinin, Mika
Huupponen, Risto
Funding for this research was provided by:
Finnish Pharmaceutical Industry Research Foundation (NA)
Article History
Received: 5 October 2020
Accepted: 4 March 2022
First Online: 12 May 2022
Declarations
:
: According to Finnish law, written consent of the interview participants or an Ethics committee evaluation was not required for this study. Participation in the study was voluntary, and the participants were informed verbally and with a written information sheet about the aim of the study and its practical implementation. The participants gave their verbal consent for the study. Recording of the discussions was acknowledged by the participants at the beginning of the interviews. The participants were informed that the results will be published without any disclosure of the identity of the respondents or their companies.
: Not applicable
: NL is employee of TFS Trial Form Support Oy, a CRO engaged in commercial clinical trials for the pharmaceutical industry. MB is an employee of a research-based pharmaceutical industry association, Pharma Industry Finland. JB is former employee of Astra Zeneca. MS is an employee, shareholder and Board member of Clinical Research Services Turku – CRST Oy, a CRO engaged in commercial clinical trials for the pharmaceutical industry. RH is member of the Advisory Board on Socio-Medical Affairs, Section for Pharmaceutical Affairs, of the Social Insurance Institution of Finland, and a former member of the Pharmaceutical Division of the Council of Choices in Health Care, Ministry of Social Affairs and Health. AA declares that she has no competing interests.